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1. Structure of a metabolic pathway 
Biologists are used to the idea that proteins or 
nucleic acids have a structure, but are surprised when 
it is suggested that a metabolic pathway has a struc- 
ture. Pathways have both a thermodynamic and a 
kinetic structure, which are complementary, but the 
latter provides an easier-to-understand explanation 
of how a steady-state flux can be maintained and, 
further, how it can be changed: one of the earliest 
papers in which some theoretical principles of meta- 
bolic control were discussed in detail was by H. A. 
Krebsin 1957 [l]. Inow submit that,inaddition, know- 
ledge of the structure of a pathway is essential in under- 
standing metabolic regulation; failure to obtain and 
apply such knowledge prior to a detailed study of 
metabolic regulation, can lead to a wastage of effort. 
These points have been discussed in two recent articles 
[2,3]. These theoretical considerations also apply to 
the question of how hormones influence the flux 
through metabolic pathways, and the quantitative 
relationship between the secondary messenger and 
hormone action; they will be discussed later in this 
article. First, it is necessary to appreciate the role of 
the non-equilibrium, near-equilibrium and flux-gener- 
ating reactions in the structure of a pathway. 
1.1. Non-equilibrium, near-equilibrium and flux- 
generating reactions 
Three types of reaction occur in metabolic path- 
ways: a single non-equilibrium reaction that approaches 
saturation with pathway-substrate (the flux-gener- 
ating step); one or more non-equilibrium reactions 
which are not saturated with pathway-substrate; and 
usually more than one near-equilibrium reaction [2]. 
A reaction is non-equilibrium because the catalytic 
activity of the enzyme is low in comparison to that 
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of the other enzymes. Hence the concentration of the 
product(s) is low, so that the rate of the reverse com- 
ponent of the reaction is very much less than the rate 
of the forward component. A reaction is near-equi- 
librium if the catalytic activity of the enzyme is high 
so that the concentration of the product(s) is high 
and the rate of the reverse component of the reaction 
is similar to that of the forward component and both 
are much greater than the overall flux. In the hypo- 
thetical example of a simple pathway given below, in 
which substrate S is converted into end-product P, 
which is removed by a further reaction E4, Er and E3 
are non-equilibrium, whereas Ez is near-equilibrium: 
El Ez E3 E4 
10.01 100 10.1 
S-_-A--B--P - 
0.01 90 0.1 
The numbers refer to the actual rates (and not the 
rate constants) in either direction. The roles that 
these classes of reactions play in a metabolic pathway 
are given below. 
1 .l .I. The flux-generating reaction 
In order to understand how a steady-state can be 
established in a metabolic pathway and how the flux 
through the pathway can be changed from one 
steady-state to another, it is first necessary to appre- 
ciate the significance of the flux-generating reaction. 
A flux-generating reaction is the first reaction in the 
pathway that is saturated with pathway-substrate 
(defined as the substrate which represents the flow 
of matter through the pathway). In the hypothetical 
metabolic pathway given above, the enzyme El catal- 
yses the flux-generating step (i.e., it approaches atu- 
ration with S). The other reactions in the pathway 
must be regulated in such a way that they are able 
to respond to the flux generated at Er. In the simplest 
situation, these reactions will be regulated via changes 
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in the concentration of their pathway-substrates (i.e., 
A,B) which are termed internal effecters. For exam- 
ple, an increase in the activity of enzyme Er will 
increase the flux through the pathway via increases 
in the concentrations of A and B, which will increase 
the activities of enzymes E2 and Ee, respectively. This 
regulatory relationship is discussed further in section 
2. The importance of the concept of the flux generat- 
ing step should be appreciated when it is considered 
that many conventional metabolic pathways, at least 
as described in many textbooks, cannot, by them- 
selves, generate or maintain a steady-state flux. They 
represent biochemical or truncated pathways which 
may be of value in understanding the function of a 
particular pathway in a given cell, but can provide 
misleading information in relation to control of the 
flux through pathway. A steady-state flux, and there- 
fore one that can be controlled, can only be achieved 
if the first step in the pathway approaches aturation 
with pathway substrate; if it is not, a decrease in the 
concentration of this substrate will reduce the activ- 
ity of the enzyme and hence the flux through the 
pathway. An example may help to explain this impor- 
tant point. In the conventional pathway of glycolysis- 
from-glucose in muscle, none of the non-equilibrium 
reactions in this pathway is saturated with pathway 
substrate. Consequently, utilisation of glucose by 
muscle could rapidly lead to a reduction in blood 
glucose concentration which, in turn, would reduce 
the rate of glycolysis. This is not a trivial point: a 
marathon runner can use at least 5 g glucose every 
minute so that, since the total amount of glucose in 
the extracellular space is only 20 g, the runner would 
be severely hypoglycaemic in 3-4 min [4]. Glycolysis 
can only be maintained if glucose is released into the 
bloodstream at a rate equal to the rate of glucose 
utilisation. This is achieved either by glucose absorp- 
tion from the intestine (in the absorptive state) or by 
glucose release from the liver (in the post-absorptive 
state). 
A flux-generating step is identified by the follow- 
ing criteria: the reaction is non-equilibrium; the Km 
of the enzyme catalysing the reaction is considerably 
lower than the in vivo substrate concentration; the 
flux through the pathway cannot be modified by 
changing the in vivo concentration of pathway-sub- 
strate of that reaction. Application of these criteria to 
several accepted metabolic pathways provides some 
interesting conclusions (see table 1). The supply of 
glucose to muscle and perhaps to other tissues is 
achieved by two pathways; one starts with glycogen 
in the muscle and represents anaerobic glycolysis 
whereas the other starts with liver glycogen and repre- 
sents aerobic glycolysis. Biochemical and physiological 
data on muscle have led to similar conclusions [5-71. 
Fatty acid oxidation in muscle starts with triglyceride 
lipase in the adipose tissue, as does fatty acid oxida- 
tion and ketogenesis in the liver [3]. By analogy, the 
citric acid cycle is really two pathways since it con- 
tains two flux-generating steps, these are catalysed by 
citrate synthase and by 2-oxo-ghrtarate dehydrogenase. 
This has considerable implications for the role of the 
citric acid cycle in muscle especially at rest but this 
will be discussed elsewhere [8]. Similarly, gluco- 
neogenesis in the liver may be two pathways since 
pyruvate carboxylase and fructose biphosphatase may 
both catalyse flux-generating steps. The importance 
of this sort of information in approaching the problem 
of metabolic control will be illustrated in sections 2 
and 3. 
1.1.2. Near-equilibrium reactions 
Probably the most important function of a near- 
equilibrium reaction in metabolic control is to pro- 
vide a high sensitivity to changes in the concentra- 
tions of substrate and/or products of the reaction. 
Table 1 
Flux-generating steps for various pathways in muscle 
Pathway Flux-generating step 
1. Glycogen to lactate 
2. Glucose to pyruvate 
3. Pyruvate to acetylCoA 
4. AcetylCoA to 2-oxoglutarate 
5. 2-Oxoglutarate to oxaloacetate 
6. Fatty acid to acetyl-CoA 
Muscle glycogen phosphorylase 
Hepatic glycogen phosphorylase 
Pyruvate dehydrogenase 
Citrate synthase 
2-Oxoglutarate dehydrogenase 
Adipose tissue triglyceride lipase 
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Consequently, they are ideal reactions to transmit 
the flux generated at the flux-generating reaction 
[2,3,9,10]. Thus, a small increase in substrate concen- 
tration could transmit alarge increase in flux generated 
at the flux-generating step. However, this high sensi- 
tivity to substrates and products means that these 
reactions are much less sensitive to the effects of 
allosteric regulators, which include the secondary 
messengers of hormones. Hence, it is unlikely that 
nearequilibrium reactions will be sites for hormonal 
control of the flux through metabolic pathways. This 
is a particularly important point which may be easily 
overlooked by endocrinologists searching for metab- 
olic effects of hormones, but who have little experi- 
ence of the theory underlying the control of flux 
through metabolic processes. 
1.1.3. Non-equilibrium reactions not saturated with 
substrate 
Non-equilibrium reactions that are not saturated 
with substrate play an important role in directing a 
pathway, particularly towards its end and in the 
middle of a long pathway. (Flux-generating steps 
determine direction of a pathway at its beginning.) 
The major advantage of the non-equilibrium reactions 
in metabolic ontrol is that the enzymes catalysing 
such reactions can be controlled by allosteric factors. 
Hence they provide potential sites for hormonal con- 
trol via the effects of secondary messengers, provided 
that this is co-ordinated with control of the flux- 
generating step. The major disadvantage of the non- 
equilibrium reaction is a poor sensitivity to changes in 
concentration of both allosteric effecters and sub- 
strates(s). Means for increasing sensitivity of such 
reactions and particularly the role of hormones in 
increasing sensitivity is discussed in section 5. 
2. Control of the flux through a physiological 
pathway 
In the following hypothetical linear pathway the 
flux Q is generated at reaction Er (the flux generat- 
ing step which is denoted by the sign a): 
This flux is transmitted along the pathway by the 
response of the subsequent reactions to the metabolic 
intermediates A, B and C, so that these metabolites 
link all the component reactions of the pathway and 
help to produce the overall steady-state flux. The role 
of the metabolic intermediates is emphasised by con- 
sideration of an activation of one of the enzymes; for 
example, compound X stimulates enzyme Ez so that, 
if the concentration of X was increased, the activity 
of this enzyme would increase. However, this would 
result in a decrease in the concentration of the sub- 
strate A which would lower the activity of enzyme 
Ez until it returned to the original activity, so that 
the overall steady-state flux would not change. The 
only difference would be a lowered steady-state con- 
centration of A. This shows that, in this example, the 
concentration of A is determined by the flux (i.e., the 
activity of the enzyme that catalyses the flux gener- 
ating step) together with the kinetic properties of 
enzyme Ez. Metabolic intermediates whose concentra- 
tions are determined by the flux (and which, there- 
fore, help to maintain the steady-state flux) are 
termed internal effecters for that flux. Two points, 
which are particularly relevant o consideration of the 
action of hormones, arise from this discussion: 
0) 
(ii) 
Hormones (or their secondary messengers) would 
only be expected to change the activity of an 
enzyme such as Ez provided that the activity of 
the enzyme that catalysed the flux generating 
step was also similarly changed (see section 3). 
Many hormones produce their intracellular 
effects via a change in concentration of a second- 
ary messenger; the concentration of a secondary 
messenger may be regulated as an intermediate of
a pathway which has a structure as indicated 
above. 
The effects of the hormone on the concentration of 
secondary messengers can be predicted from the 
structure of the pathway (see section 4). 
3. Hormonal action and the flux-generating step 
Some hormones modify the flux through metab- 
olic pathways. In general, this effect of the hormone 
is likely to be mediated through the action of an 
intracellular secondary messenger (see section 4). An 
important question is, which reactions in the pathway 
must the secondary messenger affect? At least the 
activity of the enzyme that catalyses the flux-gener- 
ating step must be changed. If the activity of this 
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enzyme is increased; e.g., the remainder of the reac- 
tions in the pathway could respond to the increased 
flux via increases in the concentrations of pathway- 
substrates (i.e., internal control). However, it is possi- 
ble that this control alone may not be sufficient at 
some non-equilibrium reactions (because of the 
insensitivity of these reactions). Therefore, it is possi- 
ble that the hormone, via the secondary messenger, 
will modify the activity of one or more ‘non-equilib- 
rium’ enzymes in the pathway in addition to that of 
the ‘flux-generating’ enzyme, as follows: 
where X is the secondary messenger. 
This theoretical approach to the action of hor- 
mones can best be explained by reference to exam- 
ples, such as the hormonal control of fatty acid oxi- 
dation in muscle and the effects of insulin on glucose 
transport and glycogen synthesis in muscle. 
3.1. Flux-generating step for fatty acid oxidation in 
muscle and effects of hormones 
It is suggested that the flux-generating step for the 
P-oxidation of fatty acids in muscle (at least as far as 
the formation of acetyl-CoA) is the lipolytic process 
in adipose tissue, which is catalysed by triglyceride 
lipase (together with di- and monoglyceride lipases) 
(see fig.1). Consequently, in order to control the rate 
of fatty acid oxidation in muscle, it is necessary to 
control the activity or triglyceride lipase within the 
adipose tissue. There are a large number of hormones 
(e.g., glucagon, adrenaline, noradrenaline, insulin, 
growth hormone, glucocorticoids) that modify the 
activity of this enzyme [1 11. Indeed, the number of 
hormones that affect the enzyme is so large that it 
prompted Steinberg in 1963 1121 to comment that, 
in consideration of discrimination and selectivity, the 
number of hormones affecting the lipase was embar- 
rassingly large. In view of the fact that triglyceride 
within adipose tissue is the major fuel store of the 
body and that the triglyceride lipase is flux-generating 
for fatty acid oxidation in muscle and in other tis- 
sues, it is not at all surprising that a large number of 
hormones affect the activity of this enzyme. 
3.2. Flux-generating steps for glucose u tilisation in 
muscle and the effects of insulin 
The flux-generating step for glycolysis-from-glu- 
Adipose tissue Blood 
hormones hormones 
Fig.1. Flux-generating step for fatty acid oxidation by muscle. 
The flux-generating step is the lipolysis of triacylglycerol to 
fatty acid (FFA) within the adipose tissue. The triacylglycerol 
lipase activity is controlled by the balance of effects of 
lipolytic and antilipolytic hormones. The fatty acids are 
transported via the bloodstream to the liver in combination 
with albumin. 
case in muscle can vary; in the post-absorptive state 
it is likely to be hepatic phosphorylase, whereas, in 
the absorptive period, after a carbohydrate-containing 
meal, glucose absorption from the intestine will be 
flux-generating (see fig.2). That the hepatic phos- 
Fig.2. Flux-generating steps for glycolysis in muscle. In the 
absorptive state, glucose transport across the luminal mem- 
brane of the epithelial cell of the intestine is probably flux- 
generating for glycolysis-from-glucose in the muscle. In the 
post-absorptive state, hepatic phosphorylase will be flux- 
generating. 
K124 
Volume 117, Supplement FEBS LETTERS 25 August 1980 
phorylase is flux-generating for glycolysis in muscle is 
consistent with the large number of hormones that 
increase the activity of this enzyme under conditions 
when glycolytic flux in muscle is increased (e.g., sus- 
tained exercise). However, it is well established that 
insulin stimulates transport of glucose into muscle, 
which is not a flux-generating step. Since insulin 
reduces the rate of glycogenolysis in the liver [ 131, it 
might be expected that it should inhibit rather than 
activate the transport of glucose across the muscle 
cell membrane. The activating effect of this hormone 
can be explained on the basis of the relationship 
between glucose absorption from the intestine and 
the stimulation by insulin of glycogen synthesis in 
muscle. Insulin stimulates the flux-generating reaction 
for glycogen synthesis in muscle, glycogen synthetase. 
However, stimulation of this enzyme alone would not 
lead to an increase in the steady-state rate of glycogen 
synthesis but would cause a reduction of the concen- 
trations of UDP-glucose and hexose monophosphates 
in muscle. It could not lead to an increase in the rate 
of conversion of extracellular glucose to glycogen, 
since there would be no stimulation of glucose trans- 
port into the muscle. Hence insulin, which is secreted 
in relation to the rate of glucose absorption from the 
intestine and which stimulates the activity of glyco- 
gen synthetase, also stimulates glucose transport. 
Thus, the flux of glucose from the intestinal lumen to 
glycogen in the muscle is facilitated by the insulin 
stimulation of the flux-generating step, glycogen syn- 
thetase and the non-flux-generating step, glucose 
transport (see fig.3). 
The major problem with the stimulation of glucose 
transport by insulin is that, if this effect occurs in the 
absence of the high rate of absorption of glucose 
from intestine, it could result in hypoglycaemia. This 
suggests hat high levels of insulin, in the absence of 
high rate of carbohydrate absorption from the gut, 
would be dangerous, ince it would increase the activ- 
ity of a non-flux generating step, and result in a 
decreased concentration of an important metabolic 
intermediate, namely blood glucose. Thus, the effec- 
tiveness of insulin as a murder weapon by medically 
knowledgeable personnel is explicable on the basis 
of this theory [ 141. 
3.3. Experimental approaches to hormone action 
These considerations suggest that hormones will 
modify the activities of enzymes that catalyse flwr 
generating steps and, in addition, enzymes that catal- 
@ 
Pancreas 
Fig.3. Effects of insulin on glucose uptake and glycogen 
synthesis in muscle. Insulin stimulates the activities of glyco- 
gen synthetase and the glucose-transporting system in muscle. 
It is suggested that only high concentrations of insulin will 
have these effects, and that such concentrations will only be 
apparent after a carbohydrate meal. 
yse other non-equilibrium reactions in the pathway, 
to provide a concerted mechanism of control. Con- 
sequently, the question as to which reaction(s) in a 
pathway, a hormone (or its secondary messenger) 
will be likely to affect, can only be answered when the 
structure of the pathway is known. The first experi- 
mental stage is to identify the near- and non-equilib- 
rium reactions in the pathway. This can be done by 
established methods [151. The second stage is to 
identify the flux-generating step, for which the exper- 
imental criteria have been given in section 1 (see also 
[2]). The demonstration that a hormone can modify 
a reaction in a pathway via external regulation is 
carried out by allowing the hormone to modify the 
flux through the pathway in an intact tissue prepara- 
tion and measuring the steady-state changes in con- 
centrations of pathway substrates. If the concentra- 
tion of substrate changes in the opposite direction to 
the flux, this indicates that external regulation, due 
to the presence of the hormone, operates at that 
reaction [2]. The identification of the external regu- 
lator (i.e., secondary messenger) is obtained by inves- 
tigating the properties of the enzyme in vitro. The 
search for the compound that activated hepatic phos- 
phorylase in response to adrenalin led to the discovery 
in 1958 of cyclic AMP [ 161. The current interest in 
factors that regulate the rate of interconversion 
between glycogen synthetase a and b in muscle is 
explained by the fact that this might lead to identifi- 
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cation of the second messenger for insulin [17]. Con- 
firmation that an effector in vitro is in fact the regu- 
lator in vivo is different and requires extension of the 
experiments to the intact system [2,15]. 
One of the major problems in metabolic control 
is that it is easy to place the biochemical cart before 
the horse. Thus, the properties of an enzyme are 
investigated in vitro and on the basis of such proper- 
ties, a hypothesis of control is put forward. If the 
hypothesis has some physiological attractions, it can 
be readily accepted despite lack of evidence that it 
has any application to the in vivo condition. Proper- 
ties of enzymes are usually obtained in a very dilute 
artificial medium in the cuvette of a given spectro- 
photometer and immediately extrapolated to the in 
vivo system. The phenomenon of ‘exciting’ properties 
being discovered in such a way has become known as 
a ‘storm in a cuvette’. Perhaps a better description of 
this situation was provided by Charles L. Dodgson 
(alias Lewis Carroll) in 187 1 [ 181 as follows: 
“As she said this, she looked up, and there was the Cat 
again, sitting on a branch of a tree. 
‘Did you say pig, or fig?‘said the Cat. 
‘Z said pig, ’ replied Alice; ‘and I wish you wouldn ‘t 
keep appearing and vanishing so suddenly: you make one 
quite giddy. ’ 
‘All right,‘said the Cat; and this time it vanished 
quite slowly, beginning with the end of the tail, and 
ending with the grin, which remained some time after the 
rest of it had gone. 
‘Well! I’ve often seen a cat without a grin’, thought 
Alice; ‘but a grin without a cat! It’s the most curious 
thing Z ever saw in all my life!’ ” 
Biochemists are almost always interested in the grin 
rather than the cat whigh Alice realised as being ‘most 
curious’. The ‘grin’, of course, can be studied as a 
phenomenon, the difficulty arises when such studies 
are extrapolated to the ‘cat’ without rigorous testing 
of such extrapolations, 
Knowledge of the structure of the pathway can 
provide some guidance as to which reactions will be 
wise to study, and the examples given in this section 
indicate the scientific success that can be achieved 
from selection of the correct reaction to study. One 
example from the recent literature illustrates the 
danger. The mitochondrial adenine nucleotide trans- 
locase catalyses the transport of ADP into the mito- 
chondria and ATP out of the mitochondria [ 191. 
This is an extremely important reaction in energy 
transfer in the cell, but the available evidence suggests 
K126 
that it is not flux-generating for energy transfer and 
that it is likely to be a near-equilibrium reaction. Con- 
sequently, it is unlikely to be a site for allosteric or 
hormonal regulation. Nonetheless, it has been sug- 
gested on the basis of experiments with isolated 
mitochondria, that the physiological effects of thy- 
roxine on energy metabolism may be explained via its 
effect on the translocase [20]. The structure of the 
energy transfer pathway in muscle would suggest hat 
this is unlikely to be a hormone sensitive reaction and 
any further in vitro studies with thyroxine on this 
process would provide information only on the ‘grin’. 
4. Secondary messengers and hormone action 
The concept of the secondary messenger was pro- 
posed by Sutherland and colleagues in 1965 [2 1 ] to 
account for the role of cyclic AMP in mediating the 
intracellular response to a hormone. In this elegant 
scheme, the hormone is seen as the primary messen- 
ger which, after release from the endocrine gland and 
transport in the bloodstream, modifies metabolism 
within the target tissue(s) by changing the concentra- 
tion of the secondary messenger. Since 1965, a con- 
siderable amount of work has been directed towards 
understanding both the molecular events by which a 
hormone interacts with a tissue and causes a change 
in the intracellular concentration of a secondary mes- 
senger, such as cyclic AMP, and how the latter pro- 
duces the physiological response in the target tissue. 
It is generally accepted that some hormones bind to 
a specific receptor on the surface of the cell, that 
this binding enhances the activity of a specific 
enzyme such as adenylate cyclase and that this leads 
to an increase in the steady-state concentration of 
the secondary messenger in the tissue. Since, the 
change in the secondary messenger concentration is 
important in producing the response to the hormone, 
the theoretical principles underlying the concentra- 
tion changes are of considerable importance. It has 
not, in general, been realised that the secondary mes- 
senger system is formally analogous to a metabolic 
pathway and must comprise a structure as described 
in section 1. Maintenance of steady-state concentra- 
tions and the ability to change this concentration 
demand an organ&d structure. The earlier discussion 
concerned the origin and control of flux, but since 
flux and concentrations of intermediates are intimately 
related, changes in flux will produce defined changes 
Volume 117, Supplement FEBS LETTERS 25 August 1980 
in the concentration of an intermediate involved in 
the transmission of that flux. Thus, the concentration 
of a secondary messenger can be predicted if the flux 
and the properties of the enzymes that utilise the 
messenger are known. 
A simple model for a pathway which produces and 
utilises a secondary messenger X is described as fol- 
lows: 
enzymes should be studied in detail in vitro but 
knowledge of the properties of these enzymes enable 
the concentration of the secondary messenger to be 
calculated. Thus, the system can be described 
mathematically and the concentration of X is given 
by the following equation: 
s ,;i )X a2 )B- 
PI = 
‘E, OKmE 
cvE2 - vE;) 
The term ‘utilises’ is used in the context of sec- 
ondary or local messengers to mean conversion of the 
messenger to a less active or non-active metabolite of 
the messenger. 
where V& and PEZ are the maximal activities of 
enzymes El and Ez, respectively, and K 
In this model, El is the flux generating reaction 
and Ez is a non-equilibrium reaction. It is important 
to appreciate that the reaction catalysed by El must 
be flux generating (or pseudo-flux generating; see 
[2]) if changes in the activity of this enzyme are to 
modify the steady-state concentration of the second- 
ary messenger, X. If this reaction were not flux gener- 
ating, a change in the activity of the enzyme would 
not change the flux through this pathway, so that 
there would be no change in the steady-state concen- 
tration of X. On the other hand, changes in the activ- 
ity of enzyme Ez should always cause a change in 
the steady-state concentration of X, although there 
would be no change in the flux through the pathway. 
mE2 
is the Km 
of E2 for X (see appendix A for derivation of equa- 
tion). The usefulness of the model is that from a 
knowledge of the quantitative effect(s) of the hor- 
mone on enzymes Er (assuming it catalyses a flux- 
generating reaction) and/or E2, precise changes in the 
concentration of the secondary messenger are predict- 
able. It is assumed that the flux through the pathway 
is equal to the maximal activity of enzyme El. and 
that the activity is changed by the effect of the hor- 
mones. 
Once a secondary messenger system is identified, 
it is tacitly assumed that changes in the enzyme that 
produces the messenger must always be capable of 
changing the concentration of the messenger. The 
danger is that the enzyme will be studied in vitro 
and any properties that are discovered in this way 
could immediately be assumed to apply to the situa- 
tion in vivo. Such properties will only be relevant to 
changes in the concentration of secondary messenger 
if the ‘secondary messenger-producing enzyme’ catal- 
yses a flux generating reaction. These considerations 
lead to the important question, does adenyl cyclase 
catalyse a flux-generating step? If it does not, it is 
possible that all the properties concerning hormone 
activation or receptor interaction may be of little 
value for understanding how the changes in the 
steady-state concentration of cyclic AMP are brought 
about. It has indeed been shown that adenyl cyclase 
catalyses a flux-generating step [22]. 
Although this model provides a useful introduc- 
tion it is an oversimplification. Thus, for many sec- 
ondary messenger systems the utilisation process 
comprises at least two reactions, which have different 
properties. This complication must be included in the 
model. For the cyclic AMP system, there are at least 
two phosphodiesterase nzymes whose properties are 
different. The following reaction sequence describes 
the model for cyclic AMP: 
AMP 
2-Y 
1. 
ATP- cyclic AMP / 
\ 
3. 
\r 
AMP 
The activities of adenylate cyclase and high- and 
low-K, phosphodiesterase are represented by I,2 
and 3 respectively. The following assumptions are 
implicit in the model: 
(i) Adenylate cyclase is the flux-generating step and 
its maximal activity under any given condition 
represents the flux through the cyclic AMP path- 
way; 
(ii) All three enzymes catalyse non-equilibrium reac- 
tions; 
The structure of the ‘secondary messenger path- (iii) Both phosphodiesterase nzymes obey Michaelis- 
way’ is useful not only from indicating which Menten kinetics. 
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Consequently, the model is described mathematically 
as follows: 
where S is the concentration of cyclic AMP and sub- 
scripts 1,2 and 3 refer to the enzyqes as indicated 
above. Consequently, the concentration, S, can be 
calculated from the equation: 
S=-b+dm 
242 
(see appendix B for derivation of equation) 
where a =(V* + v3 - V,) 
b = (V&m3 + V&m, - VlKm, - VlKm2) 
Thus, the basal concentration of cyclic AMP in a 
tissue can be calculated from the above equation 
from values of the maximal activities for the three 
enzymes and values of Km for the two phosphodies- 
terase enzymes. In addition, the increase in the con- 
centration of cyclic AMP produced by the action of a 
hormone can also be quantitatively predicted if the 
effects of the hormone on the cyclase and phospho- 
diesterase nzymes are known. The relevant informa- 
tion would be included in the mathematical model 
given above. 
The basal and hormone-stimulated activities of 
adenylate cyclase and the maximal activities and Km 
values of the two phosphodiesterases have been mea- 
sured in many different tissues so that the concentra- 
tion of cyclic AMP can be calculated according to the 
model [22]. Where possible, the calculated concentra- 
tions of cyclic AMP have been compared to the mea- 
sured concentrations reported in the literature [22]. 
In general, there is reasonable agreement between 
calculated and reported concentrations although, in 
some tissues, there are marked differences for both 
the basal and hormone-stimulated concentrations 
(i.e., gastrocnemius muscles of both the mouse and 
rat and heart ventricle of the frog). In these latter 
cases, the calculated concentration is almost an order 
of magnitude lower than the measured concentration. 
However, if only the extent of stimulation by the 
hormone is considered (i.e., stimulated concentra- 
tion/basal concentration) there is remarkable agree- 
ment. This suggests that the actual measurements of 
cyclic AMP may be in error and that the model has 
some validity [.22]. 
Most discussions of secondary messengers in the 
literature centre on the cyclic nucleotides and more 
recently on Ca2+. Consideration of the secondary 
messenger as an intermediate in a physiological metab- 
olic pathway enables other messenger systems, which 
have not usually been considered to have any metab- 
olic similarity to the cyclic nucleotide systems, to be 
included in a secondary messenger classification. In 
addition to Ca2+, neurotransmitters and adenosine 
can be included. 
4.1. Calcium ions as secondary messengers 
In resting muscle, most of the Ca2+ in the fibre is 
contained within the sarcoplasmic reticulum and the 
mitochondria [23]. The action potential causes a 
release of Ca2+ from the reticulum resulting in an 
increase in the sarcoplasmic concentration of Ca2+, 
which causes activation of the myofibrillar ATPase 
(and hence contraction). The sarcoplasmic Ca2+ con- 
centration is lowered by re-uptake into the sarcoplas- 
mic reticulum and the mitochondria by a process 
that requires the utilisation of ATP [23]. Conse- 
quently this represents another messenger-model sys- 
tem: 
sarcoplasm ADP 
/ 
/ ATP 
2+ / 2+ 
Ca / 
/ 
4+ 
) Ca 
i 
Ca 
2+ 
la $ 
sarcoplasmic activation of Y/I sarcoplasmic 
reticulum myofibrillar reticulum 
ATPa se 
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It is suggested that the Ca’+-release process is flux- 
or pseudo-flux-generating and that Ca*+ uptake by 
the reticulum is first order, for which there is some 
evidence [23,24]. This messenger system could be 
quantitatively analysed by the model similar to that 
for cyclic AMP described above. 
AMP 
\r Inosine 
4.2. Neurotransmitters as secondary messengers 
Most if not all neurotransmitters are concentrated 
in vesicles in the presynaptic nerve terminals. The 
process of exocytosis causes release of the contents 
of these vesicles into the synaptic cleft. The neuro- 
transmitter is ‘utilised’ either by re-absorption into 
the pre-synaptic nerve terminal and/or by enzymatic 
destruction in the cleft. Acetylcholine is used as an 
The properties of these enzymes from rat heart have 
been investigated in detail and a model system, based 
on these properties, has been proposed in [28]. 
5. Hormonal action and sensitivity in metabolic 
control 
The above discussion has focused on one impor- 
example to illustrate how the messenger-model can be tant aspect of metabolic control, the identification of 
applied to neurotransmitters: reactions that should be affected by hormones or 
choline l exocytosis , acetylroline 
Acetate 
acetyl- acetylcholln- esteras; , +_ 
cell biochemical action on 
membrane of postsynaptic membrane 
presynaptic 
nerve 
It is suggested that the exocytotic process is either 
flux-generating or pseudo-flux-generating. The utilisa- 
tion of acetylcholine, on the other hand, is probably 
first order. Thus, the Km value of brain acetylcholin- 
esterase for acetylcholine is about 100 PM [25] but 
it is likely that the concentration of acetylcholine in 
the synaptic cleft is much less than this, since as little 
as 0.0001 E.~M acetylcholine excites or inhibits many 
organs and tissues, and 1 MM acetylcholine is sufficient 
for a maximal response [26]. If the flux through the 
system and the properties of the utilisation system 
were known, it would be possible to analyse the sys- 
tem quantitatively. 
4.3. Adenosine as a secondary messenger 
Adenosine is considered to be produced from 
AMP by the action of 5’-nucleotidase and it is utilised 
by the action of adenosine deaminase and adenosine 
kinase. Adenosine is considered to have a number of 
regulatory roles in both biochemical and physiological 
processes [27]. Consequently, the control of the con- 
centration of this messenger may be described by the 
following model system: 
their secondary messengers. This approach enables 
properties of enzymes to be investigated in vitro with 
some confidence that the properties will be of rele- 
vance in vivo. However, this implies that if hormones 
affect, directly or indirectly, a flux-generating step, 
they will cause a change in flux through that path- 
way. This is not necessarily the case. It is suggested 
that some hormones may cause changes in the control 
mechanism so that the response to other hormones or 
other regulators is markedly increased. In order to 
understand how this could be brought about, it is 
necessary to appreciate the problems of sensitivity in 
metabolic control. 
4.4. Sensitivity in metabolic control 
Sensitivity can be defined as a function that mea- 
sures the magnitude of a response to given stimulus 
(e.g., the change in flux through a metabolic pathway 
in response to a change in concentration of a second- 
ary messenger, i.e., the ratio of the relative (percent- 
age) change in the response to the relative change in 
stimulus). If the concentration of a messenger (x) 
changes by AX, the relative change is A [x] / [x]; if 
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the change in [x] modifies the flux through a meta- 
bolic pathway from J to AJ, the sensitivity of J to the 
change in [x] is given by the ratio (M/J)/(A [xl/ [xl). 
The sensitivity as the mathematical limit of this ratio 
is denoted by the symbol si, so that: 
s; = (dJ/J)l(d [xl I [xl > 
= d W/d In [x] 
However, the interpretation of what is meant by 
sensitivity is probably easier to understand if this 
equation is integrated to provide a power equation 
[lo]: 
J 
J= h[xlSX 
where A is a constant of integration whose value is 
not required for the present analysis. Although there 
are limitations in the use of this equation for calcula- 
tion of sensitivity [lo], it is useful in providing a 
means for comparing the effectiveness of various 
mechanisms for increasing sensitivity. Although there 
are a large number of different mechanisms for spe- 
cific control of different enzymes, when the problem 
of improving sensitivity of non-equilibrium reactions 
to changes in concentrations of regulators i con- 
sidered, if can be seen that the mechanisms can be 
separated into a very small number of classes. Hor- 
mones play a role in a least wo of these classes. 
4.4.1. Requirement for sensitivity in metabolic 
control 
If an enzyme responds* in a hyperbolic manner to a 
change in concentration of a messenger, the value of 
the sensitivity in the above power equation will vary 
between 1 and 0. Consequently, if the flux through 
the reaction is required to increase loo-fold, the smal- 
lest possible change in messenger to produce this 
effect would be greater than loo-fold. 
In many cases, the flux through a metabolic path- 
way can change by greater than loo-fold. Indeed, in 
order to provide the energy for sprinting, the rate of 
glycolysis-from-glycogen increases by at least lOOO- 
fold in the leg muscles of man [29,30]. If the 
response of the non-equilibrium reactions of glycoly- 
sis to the regulators were hyperbolic, this would 
require a greater than lOOO-fold increase in the con- 
centrations of the regulator(s). Does this occur? Two 
non-equilibrium reactions in this pathway are those 
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catalysed by glycogen phosphorylase and phospho- 
fructokinase. The activity of the latter enzyme is 
regulated by changes in the concentrations of ATP, 
AMP, NH:, creatine phosphate, fructose bisphos- 
phate, phosphate and citrate [31]. The concentra- 
tions of most of these regulators have been measured 
in the leg muscles of man at rest and during sprinting, 
and they do not change by more than 2- or 3-fold 
[32]. Consequently, a marked improvement in sensi- 
tivity is required over that provided by the interac- 
tion of an enzyme, which catalyses anon-equilibrium 
reaction, with even a multiplicity of regulators in a 
hyperbolic manner. It is considered that this improve- 
ment is achieved by co-operativity, substrate cycles 
and interconversion cycles; these represent alogical 
series of biochemical mechanisms for improving sensi- 
tivity in metabolic ontrol [9,30]. Since some hor- 
mones appear to play a role in improving sensitivity 
by means of substrate and interconversion cycles 
these will be discussed below. 
4.5. Mechanisms for improving sensitivity in metabolic 
control 
4.5 .l . Substrate cycles 
It is possible for a reaction, which is non-equilib- 
rium in the forward direction of a pathway (i.e., A-+B; 
see below) to be opposed by a reaction that is non- 
equilibrium in the reverse direction of the pathway 
(i.e., B+ A). (Both reactions must, of course, be 
chemically distinct.) These two separate reactions are 
catalysed by enzymes Ea and E3 in the following 
hypothetical scheme: 
=* 
b 
If the two enzymes are simultaneously catalytically 
active, a substrate cycle, in which A is converted to 
B and the latter is converted back to A, is established. 
The precise quantitative role of substrate cycles in 
improving sensitivity has been developed by 
Newsholme and Crabtree [9]: the intrinsic sensitivity 
is given by (1 + cycling rate/flux). In other words, 
sensitivity will be high only when the rate of cycling 
is high and the flux is low. However, high rates of 
cycling for prolonged periods would cause a large 
amount of chemical energy to be converted into heat 
Volume 117, Supplement FEBS LETTERS 25 August 1980 
with the inherent danger of hyperthermia [9]. Hence, lead to decreases in the concentrations of creatine 
it is suggested that cycling rates will be increased only phosphate, ATP and citrate and increases in the con- 
when they are required to provide an improvement of centrations of AMP, phosphate, and NG which will 
sensitivity. The mechanism for increasing the rate of increase the activity of phosphofructokinase towards 
cycling, prior to the requirement for increased flux, its maximum. This will ensure that the rate of energy 
is considered to be hormonal. In this way, hormones production via anaerobic glycolysis increases precisely 
will not be involved nor will they interfere in the to the rate required to satisfy the demand for ATP 
basic control mechanism, but they will improve sensi- utilisation by the contractile process. It is suggested 
tivity when it is required. Thus, I consider that an that one reason for the high performance of elite 
important effect of some hormones is to increase the sprinters i  the fact that metabolic ontrol mechanisms 
rates of substrate cycling so that the sensitivity of the are so well developed that they provide maximum sen- 
control system to changes in metabolic (or other) sitivity when required in the control of the energy-pro- 
regulators i  markedly increased. This aspect of hor- ducing pathways in muscle [29]. Consequently, the 
mone action appears to have been neglected by most rate of glycolysis can be increased about lOOO-fold in 
endocrinologists, sothat we have a dearth of informa- a very short time with a minimal disturbance in the 
tion as to which hormones could affect which cycles. concentrations of glycolytic intermediates and espe- 
A speculative example is given below. cially the [ATP]/[ADP]. 
4.5.2. The fructose 6.phosphate-fructose 1,6-bis- 
phosphate cycle in the control of glycolytic 
flux and the actions of hormones 
The presence of fructose bisphosphatases in a wide 
4.5.3. Interconversion cycles 
variety of muscles from many different animals across 
the animal kingdom led Newsholme and Crabtree 
[9,33,34] to propose that this enzyme plays a role 
in the regulation of glycolysis via the operation of a 
substrate cycle between fructose 6.phosphate and 
fructose 1,6-bisphosphate. The above discussion leads 
to the suggestion that the role of this cycle in muscle 
of human subjects is to increase the sensitivity of 
metabolic ontrol at the level of fructose 6.phosphate 
phosphorylation to changes in the concentrations of
the regulators of phosphofructokinase. Because df the 
problem of hyperthermia, which results from high 
rates of cycling, it is suggested that when the subject 
is in the basal metabolic state, the rate of cycling will 
be very low. However, when exercise is anticipated, 
the rate of cycling will be raised so that the sensitiv- 
ity of the metabolic ontrol system is increased. 
Thus, it is predicted that, in the sprinter on his 
blocks, the blood levels of the stress hormones, adren- 
aline, noradrenaline, glucagon and glucocorticoids, 
will be raised to increase markedly the rate of cycling. 
This will provide a high, cycling rate:flux, ratio for 
the phosphorylation of fructose 6.phosphate while 
the sprinter is on his blocks waiting for the gun. The 
reaction will now be very sensitive to changes in the 
concentrations of the regulators of phosphofructo- 
kinase. Once the sprint is under way, the rate of 
ATP hydrolysis will increase markedly and this will 
Newsholme and Crabtree [33] pointed out that 
the mechanism of regulation of an enzyme via the 
conversion of an inactive form into an active form, 
and vice versa, has similarities to a substrate cycle 
and, indeed, that this interconversion cycle repre- 
sented a logical extension of the substrate of the sub- 
strate cycle. It has been emphasised that, in some 
situations, the substrate cycle mechanism of control 
could produce heat at too rapid a rate to provide a 
satisfactory control mechanism. Although the cycling 
between active and inactive forms of enzyme (e.g., 
between phosphorylase a and phosphorylase b or 
pyruvate dehydrogenase a and pyruvate dehydrogen- 
ase b) is similar to that of a substrate cycle, the con- 
centration of the substrate in the cycle (i.e., the 
enzymes) will, in general, be very much lower (by at 
least one order of magnitude) than those of the metab- 
olic intermediates in a substrate cycle. Hence, the 
rate of heat generation will be considerably less. How- 
ever, although the mechanism for the improvement in
sensitivity in the interconversion cycle is similar to 
that of the substrate cycle, the precise quantitative 
role of the interconversion cycle in increasing sensitiv- 
ity has not yet been defined. A qualitative description 
of the sensitivity has been provided in [9,33]. It is 
suggested above that the role of some hormones may 
be to increase the sensitivity of metabolic ontrol 
systems when required by increasing the rate of sub- 
strate cycling. Similarly, hormones could increase 
the rate of cycling in an interconversion cycle, 
without markedly changing the proportion of the 
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active form of the enzyme. However, once the cycling 
rate has been increased, the effect of a regulator on 
the activity of one or both of the interconverting 
enzymes would be to increase the rate of activation 
(or inhibition) of the target-metabolic enzyme. It is 
suggested that this may be the role of adrenaline in 
increasing the activity of phosphorylase b kinase by 
phosphorylation. Adrenaline increases the concentra- 
tion of cyclic AMP in muscle which increases the 
activity of protein kinase. The latter phosphorylates 
the P-subunit of phosphorylase b kinase, which 
increases the activity of the enzyme. However, it also 
phosphorylates the &-subunit which favours the 
dephosphorylation of the P-subunit by the phos- 
phorylase b kinase phosphatase [35]. In this way, the 
rates of both phosphorylation and dephosphoryla- 
tion of phosphorylase b kinase are increased; i.e., the 
rate of interconversion cycling is increased. In the 
case of skeletal muscle, Ca*+ are known to play an 
important role in the control of phosphorylase b 
kinase activity and hence in that of phosphorylase 
activity. If adrenaline is able to increase the rate of 
interconversion cycling between active and inactive 
forms of phosphorylase b kinase, the effect of Ca*+ 
on the rate of activation of phosphorylase (i.e., con- 
version of phosphorylase b into a) could be markedly 
increased. 
6. Conclusions 
The role of substrate cycling in metabolic regula- 
tion has been criticised on the grounds that cycling 
rates that have been measured so far are, in general, 
rather low [36]. This, however, does not take into 
account that even low rates of cycling could provide 
an improvement in sensitivity especially if cycling and 
co-operativity were combined. There is no doubt that 
a large number of substrate cycles are present in 
metabolic pathways: these include the triglyceride- 
fatty acid cycles, the protein-amino acid cycle, the 
giycogen-glucose 1 -phosphate cycle, the glucose- 
glucose 6-phosphate cycle, the fructose 6-phosphate- 
fructose 1,6-bisphosphate cycle and the pyruvate- 
phosphoenolpyruvate cycle. Although the rates of 
cycling in the cycles that have’s0 far been measured 
is low, the question arises whether the rates have been 
measured under conditions when hormone stimula- 
tion of the cycles is occurring. If any of the specula- 
tions given above are valid, hormonal stimulation of 
K132 
cycling rates could be a major form of metabolic con- 
trol which would be operative for relatively short 
times. However, during those periods the cycling rates 
should be high and sensitivity to metabolic regulators 
should also be high. This represents a novel concept 
in the consideration of hormone action and, if it has 
any validity, could be of value in understanding dis- 
eases in which there is a reduction in responsiveness 
to biochemical and physiological stimuli. Although it 
may be a novel concept in its application to hormone 
action, the general importance of substrate cycling 
was realised by Charles Dodgson in the last century 
[18]: 
“ ‘Now! Now!‘cried the Queen. <Faster! Fasterf’And 
they went so fast that at last they seemed to skim through 
the air, hardly touching the ground with their feet, till 
suddenly, just as Alice was getting quite exhausted, they 
stopped, and she found herself sitting on the ground, 
breathless and giddy. 
The Queen propped her against a tree, and said kindly, 
‘you may rest a little now’. 
Alice looked round her in great surprise. ‘Why, I do 
believe we’ve been under this tree all the time! Every- 
thing’s just as it was! ’ 
‘Of course it is,' said the Queen: ‘what would you have 
it?’ 
‘Well, in OUT country, ‘said Alice, still panting a little, 
‘you’d generally get to somewhere else-if you ran very 
fast for a long time, as we’ve been doing. ’ 
‘A slow sort of country!‘said the Queen. ‘Now here, 
you see, it takes all the running you can do, to keep in 
the same place. If you want to get somewhere else, you 
must run at least twice as fast as that!’ ” 
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Appendix A 
The reaction sequence is: 
El E2 
A-X-B 
Both reactions are non-equilibrium and are assumed 
to be enzyme catalysed; reaction A to X is zero order 
(i.e., substrate is present in excess) and the enzyme 
that catalyses the X to B reaction obeys Michaelis- 
Menten kinetics_ The equation governing this situa- 
tion is: 
V 
maxE . hE 
x= 
(‘ma+, ‘- ‘mtiE,j 
Let VmaxE be VI, VmaxE, be V2 and KmE be K. 
Then ’ 2 
The equation is derived as follows: 
dx 
z = Vl - v, 
where V, represents the actual activity of enzyme Ez. 
However: 
v, . x 
v, =- 
W+x) 
Then 
dx v, *x 
-= Vl -(K+x) 
dt 
When the sequence of reactions A + X + B is in a 
steady-state condition: 
v2x 
g=o ~*V1____= 
(K+x) ’ 
(V,K+ V,X)- V,X=O 
VIK+X(Vl -T/,)=0 
:. x = 
VIK 
(V2 - VI) 
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Appendix B 
v, *s v, .s 
v,=----t- 
K,+S K3tS 
(see text) 
This equation is solved for S as follows: 
V,(K, t S)(K, t S) = V&C, t S) t ~3Wz + s) 
V, [KzK3 t (K3 t Kz) S t S2] = [ V2K3 + v3K21s + [v2 + v31s2 
[V, t V3 - V1]s2 t [V,K, t V3K2 - VlK3 - V,K2]S - V,K2K3 = 0 
This is equivalent to: 
aS2 tbStc=O 
s_-b+@=-& 
2a 
so that: 
s = - [ v2K3 + v3K2 - V&3 - V&21 
f 
2(7/2 + v3 - VI) 
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J(V2K3 t V3K2 - VlK3 - VIK~)~ - 4(V2 t V3 - VI)(VIKZK~) 
xv2 + v3 - VI) 
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